Description
Gefticip 250mg Tablet 30’S gefticip 250mg tablets are a vital component in the treatment of certain types of cancer, specifically non-small cell lung cancer and small cell lung cancer. These tablets contain the active ingredient Gefitinib, a tyrosine kinase inhibitor that targets epidermal growth factor receptor (EGFR) mutations, which are often found in these types of lung cancer. The tablets are taken orally, once daily, and are available in a pack of 30. Gefticip offers a targeted therapy option for patients with advanced or metastatic lung cancer, helping to manage symptoms and improve quality of life. Consult with a healthcare provider to determine if Gefticip is the right treatment for you.
Reviews
There are no reviews yet.